Skip to main content

MYOMO, INC. insider trading

MYONYSE
$1.63+0.02 (+1.24%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+77.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • PRPaul R. GudonisChief Executive Officer3.6222%of company
  • TFThomas F. KirkDirector1.9505%of company
  • DADavid A. HenryChief Financial Officer1.187%of company
  • HCHeather C. GetzDirector0.5314%of company
  • MMMilton Mayo MorrisDirector0.5261%of company
  • TAThomas Aloysius Crowley Jr.Director0.39%of company
  • MMMicah MitchellChief Commercial Officer0.3301%of company
  • WJWilliam J. FebboDirector0.3123%of company
  • HKHarry KovelmanChief Medical Officer0.2278%of company
  • MJManko Joseph M. Jr.Director0.1987%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
MYOHarry KovelmanChief Medical OfficerOpen market sell$19.7K-14.7%$1.27$19.7KSep 11, 2026Sep 14, 2026
MYOMilton Mayo MorrisDirectorOpen market sell$21.2K-6.7%$1.41$21.2KSep 2, 2026Sep 4, 2026
MYOHarry KovelmanChief Medical OfficerOpen market sell$30.3K-14.2%$1.73$30.3KAug 20, 2026Aug 24, 2026
MYOThomas F. KirkDirectorOpen market purchase$50.8K+6.1%$1.27$50.8KJun 5, 2026Jun 9, 2026
MYOThomas F. KirkDirectorOpen market purchase$24.8K+4.0%$0.99$24.8KMay 28, 2026Jun 1, 2026
MYOHarry KovelmanChief Medical OfficerOpen market sell$11.8K-9.6%$1.02$11.8KMay 28, 2026May 28, 2026
MYOHarry KovelmanChief Medical OfficerOpen market sell$20.5K-14.6%$1.00$20.5KMay 27, 2026May 28, 2026
MYOThomas F. KirkDirectorOpen market purchase$39.5K+7.4%$0.91$39.5KMay 18, 2026May 18, 2026
MYOManko Joseph M. Jr.DirectorOpen market purchase$27K+1.3%$0.89$27KMay 15, 2026May 18, 2026
MYOThomas F. KirkDirectorOpen market purchase$28.8K+5.7%$0.91$28.8KMay 15, 2026May 18, 2026
MYOManko Joseph M. Jr.DirectorOpen market purchase$147K+8.1%$0.86$147KMay 14, 2026May 18, 2026
MYOMicah MitchellChief Commercial OfficerOpen market sell$77.6K-45.2%$0.86$77.6KMay 14, 2026Jun 8, 2026
MYOHeather C. GetzDirectorOpen market purchase$14K+17.9%$0.70$14KMar 16, 2026Mar 17, 2026
MYOThomas F. KirkDirectorOpen market purchase$51.1K+14.9%$0.71$51.1KMar 13, 2026Mar 16, 2026
MYOHeather C. GetzDirectorOpen market purchase$51.1K+167.7%$0.73$51.1KMar 12, 2026Mar 12, 2026
MYOThomas F. KirkDirectorOpen market purchase$1.83K+0.5%$0.72$1.83KNov 21, 2025Nov 24, 2025
MYOThomas F. KirkDirectorOpen market purchase$3.53K+1.0%$0.72$3.53KNov 20, 2025Nov 24, 2025
MYOThomas Aloysius Crowley Jr.DirectorOpen market purchase$296+0.5%$0.77$296Nov 19, 2025Nov 21, 2025
MYOThomas Aloysius Crowley Jr.DirectorOpen market purchase$2.92K+5.5%$0.73$2.92KNov 18, 2025Nov 21, 2025
End of history · 19 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.